Jefferies Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1188 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1199 |
|
|
2021
Q3 | – | Sell |
-5,023
| Closed | -$489K | – | 1225 |
|
|
2021
Q2 | $489K | Buy |
5,023
+23
| +0.5% | +$2.24K | ﹤0.01% | 733 |
|
|
2021
Q1 | $585K | Hold |
5,000
| – | – | 0.01% | 672 |
|
|
2020
Q4 | $556K | Hold |
5,000
| – | – | ﹤0.01% | 630 |
|
|
2020
Q3 | $594K | Hold |
5,000
| – | – | 0.01% | 550 |
|
|
2020
Q2 | $566 | Buy |
5,000
+3,500
| +233% | +$396 | 0.01% | 514 |
|
|
2020
Q1 | $100K | Sell |
1,500
-9,828
| -87% | -$655K | ﹤0.01% | 942 |
|
|
2019
Q4 | $1.03M | Sell |
11,328
-15,344
| -58% | -$1.4M | 0.01% | 769 |
|
|
2019
Q3 | $2.3M | Sell |
26,672
-19,949
| -43% | -$1.72M | 0.02% | 469 |
|
|
2019
Q2 | $4.89M | Buy |
46,621
+15,685
| +51% | +$1.64M | 0.04% | 181 |
|
|
2019
Q1 | $3.88M | Buy |
30,936
+2,057
| +7% | +$258K | 0.03% | 236 |
|
|
2018
Q4 | $3.26M | Buy |
28,879
+24,269
| +526% | +$2.74M | 0.03% | 272 |
|
|
2018
Q3 | $987K | Buy |
+4,610
| New | +$987K | 0.01% | 730 |
|
|
2016
Q3 | – | Sell |
-2,857
| Closed | -$26K | – | 1382 |
|
|
2016
Q2 | $26K | Hold |
2,857
| – | – | ﹤0.01% | 1156 |
|
|
2016
Q1 | $24K | Hold |
2,857
| – | – | ﹤0.01% | 1213 |
|
|
2015
Q4 | $35K | Hold |
2,857
| – | – | ﹤0.01% | 1216 |
|
|
2015
Q3 | $174K | Buy |
+2,857
| New | +$174K | ﹤0.01% | 1093 |
|
|
2015
Q2 | – | Sell |
-92,571
| Closed | -$6.29M | – | 2459 |
|
|
2015
Q1 | $6.29M | Buy |
+92,571
| New | +$6.29M | 0.04% | 124 |
|
|
2014
Q4 | – | Sell |
-25,714
| Closed | -$2.71M | – | 1389 |
|
|
2014
Q3 | $2.71M | Buy |
+25,714
| New | +$2.71M | 0.02% | 247 |
|
|
2013
Q4 | – | Sell |
-777
| Closed | -$172K | – | 1380 |
|
|
2013
Q3 | $172K | Buy |
+777
| New | +$172K | ﹤0.01% | 999 |
|